Imagine a hidden danger lurking in many common medications, from life-saving antibiotics to crucial chemotherapy drugs or even the dyes used in important medical scans. These essential treatments, while vital, sometimes carry a serious side effect: the potential to harm our kidneys, leading to a condition known as Acute Kidney Injury

Acute kidney injury (AKI) is a serious medical condition that can range from a mild, temporary disruption to severe, permanent damage, potentially leading to the complete failure of the kidneys. This can be a devastating diagnosis, impacting a person's quality of life and potentially requiring intensive medical intervention

Chronic Kidney Disease (CKD) is a silent killer that disproportionately affects Black and LatinX communities. Despite this stark reality, these communities remain underrepresented in clinical trials for new CKD drugs. This disparity not only hinders the development of effective treatments tailored to these populations but also perpetuates existing health inequities. This blog post serves as a call to action, emphasizing the urgent need for increased enrollment of Black and LatinX individuals in CKD drug research. We will explore the reasons behind this underrepresentation, the potential benefits of participation, and provide a list of free informational resources to empower individuals to make informed decisions about clinical trial participation.